Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

H1428000

Hydroxocobalamin

European Pharmacopoeia (EP) Reference Standard

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C62H89CoN13O15P
Numero CAS:
13422-51-0
Peso molecolare:
1346.36
Codice UNSPSC:
41116107
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

hydroxocobalamin

Produttore/marchio commerciale

EDQM

applicazioni

pharmaceutical (small molecule)

Formato

neat

Condizioni di spedizione

wet ice

Temperatura di conservazione

−20°C

InChI

1S/C62H89N13O14P.Co.H2O/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H2,63,77)(H2,64,78)(H2,65,79)(H2,66,80)(H2,67,81)(H2,68,82)(H,69,83)(H,85,86);;1H2/q-2;+2;-1/p-1/t31-,34+,35+,36+,37-,41+,52+,53+,56?,57-,59+,60-,61-,62-;;/m0../s1
PJOHJFIDLYDPIZ-PMEYKKDOSA-M

Categorie correlate

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Hydroxocobalamin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Ci dispiace, ma al momento non ci sono COA disponibili online per questo prodotto.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 10

1 of 10

Dicyanocobinamide ≥93%

Sigma-Aldrich

C3021

Dicyanocobinamide

Vitamina B12 analytical standard

Supelco

47869

Vitamina B12

Vitamina B12 meets USP testing specifications

Sigma-Aldrich

C3607

Vitamina B12

DL-Aspartic acid potassium salt hemihydrate ≥98.0% (NT)

Sigma-Aldrich

11240

DL-Aspartic acid potassium salt hemihydrate

Vitamina B12 European Pharmacopoeia (EP) Reference Standard

C3000000

Vitamina B12

Vitamina B12 tested according to Ph. Eur.

Sigma-Aldrich

43107

Vitamina B12

Vitamina B12 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

V-019

Vitamina B12

Vitamina B12 BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%

Sigma-Aldrich

V6629

Vitamina B12

Amberlite™ XAD®-2 pkg of 100 g

Supelco

20275

Amberlite™ XAD®-2

Vitamina B12 pharmaceutical secondary standard, certified reference material

Supelco

PHR1234

Vitamina B12

Emilie Cornec-Le Gall et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 63(1), 119-123 (2013-11-12)
A 20-year-old man was hospitalized for malignant hypertension, mechanical hemolysis, and kidney failure. Kidney biopsy confirmed glomerular and arteriolar thrombotic microangiopathy. Etiologic analyses, which included ADAMTS13 activity, stool culture, complement factor proteins (C3, C4, factor H, factor I, and MCP
Hydroxocobalamin hinders hemodialysis.
Samuel J Stellpflug et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 62(2), 395-395 (2013-06-19)
Zhuo Huang et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics, 51(3), 194-198 (2013-06-12)
Combined methylmalonic acidemia with homocystinuria is a common form of methylmalonic acidemia in China. Patients with this disease can progress to death without timely and effective treatment. This study aimed to analyze the treatment outcomes of patients with combined methylmalonic
A man with tingling fingers.
Neal Larkman et al.
BMJ (Clinical research ed.), 346, f1443-f1443 (2013-03-20)
I Vaz Matos et al.
Molecular genetics and metabolism, 109(4), 360-365 (2013-06-12)
CblC deficiency produces a combination of methylmalonic aciduria (MMA) and homocystinuria (HCU), and is the most common error of cobalamin metabolism. Patients present a wide spectrum of symptoms, ranging from early severe multisystemic forms, to milder late-onset phenotypes. Cognitive and
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.